Verseon International Corporation, the company leading a technology-driven transformation of the pharmaceutical industry, announces that it has acquired Edammo, Inc.
Verseon has spent much of the past two decades pioneering scientific advances in molecular physics, chemistry, biology, and AI to create the world's most advanced drug-discovery platform. This platform now systematically produces entire families of novel drug candidates that cannot be found by any other current method
